Loading...
•
Jun 30, 2024
Balchem Q2 2024 Earnings Report
Balchem delivered solid second quarter financials with record earnings from operations and adjusted EBITDA.
Key Takeaways
Balchem Corporation reported a 1.2% increase in net sales to $234.1 million for the second quarter of 2024. GAAP net earnings increased by 6.5% to $32.1 million, with earnings per share at $0.98. Adjusted EBITDA reached a record $62.3 million, a 5.0% increase from the prior year quarter. The Human Nutrition and Health and Specialty Products segments showed strong sales and earnings growth.
Net sales increased by 1.2% to $234.1 million compared to the prior year quarter.
Adjusted EBITDA reached a record $62.3 million, a 5.0% increase from the prior year quarter.
GAAP net earnings increased by 6.5% to $32.1 million, with earnings per share at $0.98.
Human Nutrition and Health and Specialty Products segments delivered strong sales and earnings growth.
Balchem
Balchem
Forward Guidance
We are well positioned in the markets we serve and remain confident in the long-term growth outlook for our company as we continue to focus on progressing our strategic growth initiatives in 2024 and beyond.